Evidence map›Paper›PMID 35305670›Full record

ArticleJournal of nanobiotechnology2022

H

Youlu Chen, Zuoguan Chen, Jianwei Duan, Liang Gui, Huiyang Li, Xiaoyu Liang, Xinxin Tian, Kaijing Liu, Yongjun Li, Jing Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. How Advanced Is Nanomedicine for Atherosclerosis?International journal of nanomedicine · 2025
    Review
  7. Article
  8. Article
  9. Multiscale physics-basedFrontiers in drug delivery · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Youlu Chen *Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Zuoguan Chen *Department of Vascular Surgery, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Science and Peking Union Medical College, 1 Dahua Road, Beijing, 100730, People's Republic of China.
Jianwei DuanTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Liang GuiDepartment of Vascular Surgery, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Science and Peking Union Medical College, 1 Dahua Road, Beijing, 100730, People's Republic of China.
Huiyang LiTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Xiaoyu LiangTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Xinxin TianTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Kaijing LiuTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China.
Yongjun LiDepartment of Vascular Surgery, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Science and Peking Union Medical College, 1 Dahua Road, Beijing, 100730, People's Republic of China. liyongjun4679@bjhmoh.cn.
Jing YangTianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, 236 Baidi Road, Tianjin, 300192, People's Republic of China. yangjing37@hotmail.com.ORCID http://orcid.org/0000-0003-3848-5958
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

CAMS Innovation Fund for Medical Sciences 2017-12M-1-016CAMS Innovation Fund for Medical Sciences 2018-12M-1-002National Key Research and Development Project 2018YFC2000300PUMC Discipline Construction Project 201920102101the National Natural Science Foundation of China 31771097the National Natural Science Foundation of China 81870351the National Natural Science Foundation of China 82072080Tianjin Research Program of Application Foundation and Advanced Technology (17JCZDJC37400
6 · The paper itself

Abstract

Peripheral vascular disease (PVD) is a common clinical manifestation of atherosclerosis. Vascular endothelial growth factor (VEGF) gene therapy is a promising approach for PVD treatment. However, due to single-gene therapy limitations and high H

Indexed as

Nerve Growth FactorVascular Endothelial Growth Factor AAnimalsHindlimbHydrogen PeroxideIschemiaMiceHydrogen PeroxideNerve Growth FactorVascular Endothelial Growth Factor AAngiogenesisGene therapyHydrogen peroxideNerve growth factorVascular endothelial growth factor

Identifiers

PMID35305670
PMCPMC8934504
OpenAlexW4220663615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.